Table 2 Association of demographic and clinical factors with video capsule endoscopy findings
Patient characteristics | Total n (%) | With positive findings | Without positive findings | ||
|---|---|---|---|---|---|
n | % (95% CI) | n | % (95% CI) | ||
Total | 123 | 67 | 54.5 (45.3–63.5) | 56 | 45.5 (36.5–54.8) |
Age | |||||
< 60 years | 23 (18.7) | 8 | 34.8 (16.4–57.3) | 15 | 65.2 (42.7–83.6) |
≥ 60 years | 100 (81.3) | 59 | 59.0 (48.7–68.7) | 41 | 41.0 (31.3–51.3) |
Type of bleeding | |||||
Occult | 85 (69.1) | 48 | 56.5 (45.3–67.2) | 37 | 43.5 (32.8–54.7) |
Overt (melena) | 23 (18.7) | 13 | 56.5 (34.5–76.8) | 10 | 43.4 (23.2–65.5) |
Overt (bright) | 6 (4.9) | 2 | 33.3 (4.3–77.7) | 4 | 66.7 (22.3–95.7) |
Haemoglobin (g/L) | |||||
Mild | 35 (28.5) | 16 | 45.7 (28.8–63.4) | 19 | 54.3 (36.7–71.2) |
Moderate | 52 (42.3) | 24 | 46.2 (32.2–60.5) | 28 | 53.8 (39.5–67.8) |
Severe | 36 (29.3) | 27 | 75 (57.8–87.9) | 9 | 25.0 (12.1–42.2) |
Ferritin (ug/L) | |||||
≥ 15 | 30 (24.4) | 13 | 43.3 (25.5–62.6) | 17 | 56.7 (37.4–74.5) |
< 15 | 64 (52.0) | 32 | 50 (37.2–62.8) | 32 | 50 (37.2–62.8) |
NSAID: yes | 62 (50.4) | 32 | 51.6 (38.6–64.5) | 30 | 48.4 (35.5–61.4) |
Transfusion: yes | 19 (15.4) | 11 | 57.9 (33.5–79.8) | 8 | 42.1 (20.3–66.5) |
Iron replacement: yes | 57 (46.3) | 27 | 47.4 (33.9–61.0) | 30 | 52.6 (39.0–66.0) |
Diabetes: yes | 27 (22.0) | 15 | 55.6 (35.3–74.5) | 12 | 44.4 (25.5–64.7) |